The effect of silver nanoparticles on Staphylococcus epidermidis biofilm biomass and cell viability

Editorial

Authors

1 Students Research Committee, Ph.D. Candidate, Department of Food and Drug Control, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

2 Students Research Committee, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

3 Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Objective(s):
Bacterial biofilm has been considered responsible for many deaths and high health costs worldwide. Their better protection against antibacterial agents compared to free living cells leads to poor treatment efficiency. Nanotechnology is promising approach to combat biofilm infections. The aim of the present study was to eradicate Staphylococcus epidermidis biofilm with silver nanoparticles (SNPs).
Materials and Methods:
SNPs were used at different concentrations (two fold dilutions) and incubation times (24, 48, 72 h). The crystal violet staining and pour plate assays were used to assess biofilm biomass and bacterial viability, respectively. The ability of SNPs on biofilm matrix eradication was assessed through optical density ratio (ODr). Positive control was defined as an ODr =1.0.
Results:
The crystal violet assay indicated that the biofilm matrixes were intact at different concentrations of SNOs and incubation times. There were no significant differences between these parameters (P >0.05). Bacterial enumeration studies revealed that higher concentrations of SNPs were more effective in killing bacteria than lower ones. Although, longer incubation times  led to enhancement of anti-biofilm activity of SNPs.

Conclusion:
The anti-biofilm activity of SNPs was concentration- and time-dependent. The results of this study highlighted that SNPs were effective against cell viability; however they were ineffective against biomass.

Keywords

References

  1. Eftekhar F, Dadaei T. Biofilm formation and detection of icaAB genes in clinical isolates of methicillin resistant Staphylococcus aureus. Iran J Basic Med Sci. 2011; 14(2): 132-136.
  2. Agostinho A, James G, Wazni O, Citron M, Wilkoff BD. Inhibition of Staphylococcus aureus biofilms by a novel antibacterial envelope for use with implantable cardiac devices. Clin Transl Sci. 2009; 2(3): 193-198.
  3. Bose S, Ghosh AK. Biofilms A challenge to medical science. J Clin Diagn Res. 2011; 5(1): 127-130.
  4. Campoccia D, Montanaro L, Ravaioli S, Pirini V, Cangini I, Arciola CR. Exopolysaccharide production by Staphylococcus epidermidis and its relationship with biofilm extracellular DNA. Int J Artif Organs. 2011; 34(9): 832-839.
  5. Shunmugaperumal T. Microbial colonization of medical devices and novel preventive strategies. Recent Pat Drug Deliv Formul. 2010; 4(2): 153-173.
  6. Chakraborty SP, Sahu SK, Pramanik P, Roy S. In vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureus. Int J Pharm. 2012; 436(1-2): 659-676.
  7. Taylor EN, Webster TJ. Multifunctional magnetic nanoparticles for orthopedic and biofilm infections. Int J Nanotechnol. 2011; 8 (1-2): 21-35.
  8. Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces. 2010; 79(2): 340-344.
  9. Sawosz E, Chwalibog A, Szeliga J, Sawosz F, Grodzik M, Rupiewicz M, et al. Visualization of gold and platinum nanoparticles interacting with Salmonella Enteritidis and Listeria monocytogenes. Int J Nanomedicine. 2010; 5: 631-637.
  10. Wei-Qin L, Jia-Lin Y, Guan-Xin L, Xiang-Na G, Xiu-Ju Z, Li-Ting L. Effect of silver nanopartical on the structure of Staphylococcus epidermidis biofilm. Chinese Journal of Antibiotics. 2011; 36: 394-397.
  11. Brandt YI, Armijo LM, Rivera AC, Plumley JB, Cook NC, Smolyakov GA, et al. Effectiveness of tobramycin conjugated to iron oxide nanoparticles in treating infection in cystic fibrosis. SPIE Proceedings. 2013; 8595. doi:  10.1117/12.2009549.
  12. Cabal B, Cafini F, Esteban-Tejeda L, Alou L, Bartolomé JF, Sevillano D, et al. Inhibitory effect on in vitro Streptococcus oralis biofilm of a soda-lime glass containing silver nanoparticles coating on Titanium Alloy. PLoS ONE. 2012; 7. doi: 10.1371/journal.pone.0042393.
  13. Chen X, Schluesener HJ. Nanosilver: A nanoproduct in medical application. Toxicol Lett. 2008; 176(1): 1-12.
  14. Hajipour MJ, Fromm KM, Akbar Ashkarran A, Jimenez de Aberasturi D, Larramendi IRD, Rojo T, et al. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012; 30(10): 499-511.
  15. Hamouda IM. Current perspectives of nanoparticles in medical and dental biomaterials. J Biomed Res. 2012; 26(3): 143-151.
  16. Fazly Bazzaz BS, Khameneh B, Jalili-Behabadi MM, Malaekeh-Nikouei B, Mohajeri SA. Preparation, characterization and antimicrobial study of a hydrogel (soft contact lens) material impregnated with silver nanoparticles. Cont Lens Anterior Eye. 2014; 37(3): 149-152.
  17. Babapour A, Yang B, Bahang S, Cao W. Low-temperature sol-gel-derived nanosilver-embedded silane coating as biofilm inhibitor. Nanotechnology. 2011; 22(15): 155602. doi: 10.1088/0957-4484/22/15/155602.
  18. Fabrega J, Zhang R, Renshaw JC, Liu WT, Lead JR. Impact of silver nanoparticles on natural marine biofilm bacteria. Chemosphere. 2011; 85(6): 961-966.
  19. Ahamed M, AlSalhi MS, Siddiqui M. Silver nanoparticle applications and human health. Clin Chim Acta. 2010; 411(23-24): 1841-1848.
  20. Bruzual I, Riggle P, Hadley S, Kumamoto CA. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. JAntimicrob Chemother. 2007; 59(3): 441-450.
  21. Wu WS, Chen CC, Chuang YC, Su BA, Chiu YH, Hsu HJ, et al. Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. J Microbiol Immunol Infect. 2013; 46(2): 89-95.
  22. Cerca N, Martins S, Cerca F, Jefferson KK, Pier GB, Oliveira R, et al. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother. 2005; 56(2): 331-336.
  23. Choi O, Yu CP, Esteban Fernández G, Hu Z. Interactions of nanosilver with Escherichia coli cells in planktonic and biofilm cultures. Water Res. 2010; 44(20): 6095-6103.
  24. Moghadas-Sharif N, Fazly Bazzaz BS, Khameneh B, Malaekeh-Nikouei B. The effect of nanoliposomal formulations on Staphylococcus epidermidis biofilm. Drug Dev Ind Pharm. 2014.Early Online: 1–6 DOI: 10.3109/03639045.2013.877483
  25. Jones MN, Kaszuba M, Reboiras MD, Lyle IG, Hill KJ, Song YH, et al. The targeting of phospholipid liposomes to bacteria. Biochim Biophys Acta. 1994; 1196(1): 57-64.
  26. Kim HJ, Gias ELM, Jones MN. The adsorption of cationic liposomes to Staphylococcus aureus biofilms. Colloids Surf A Physicochem Eng Asp. 1999; 149(1-3): 561-570.
Nanomedicine Journal
Volume 1, Issue 5 - Serial Number 5
October 2014
Pages 302-307

Files

Share

How to cite

Statistics